Beximco

Transcom Group CEO and Eskayef managing director Simeen Rahman on Tuesday launched coronavirus oral drug molnupiravir at its Banani office in the capital. Physicians and Eskayef top officials were present.

Eskayef starts marketing molnupiravir

Eskayef, one of the top pharmaceutical companies of the country, has brought molnupiravir to the Bangladesh market. This is the first approved drug for treatment of coronavirus across the world.

Eskayef gets approval for emergency marketing of oral antiviral molnupiravir

Eskayef gets approval for emergency marketing of oral antiviral molnupiravir

The Directorate General of Drug Administration (DGDA) has given Eskayef Pharmaceuticals, a leading drug manufacturer of the country, the approval for emergency marketing of molnupiravir, an oral ...

The much-awaited drug to fight coronavirus, molnupiravir, is being manufactured in Bangladesh too

New corona drug being manufactured in Bangladesh

For long there had been no drug for the treatment of coronavirus, but last week the UK government gave its approval for the new drug molnupiravir. The capsule, to be administered orally, is now being ...

Beximco Pharma acquires 54.6pc stake in Sanofi Bangladesh

Beximco Pharma acquires 54.6pc stake in Sanofi Bangladesh

The country’s leading manufacturer and exporter of medicine Beximco Pharmaceuticals has acquired a 54.6 per cent stake in Sanofi Bangladesh

Beximco LPG sings deal with Jamuna Oil to sell LPG at pumps

Beximco LPG sings deal with Jamuna Oil to sell LPG at pumps

The signing ceremony took place at the Chattogram office of Jamuna Oil Company on Wednesday.

Dhaka Stock Exchange

Stocks perform mixed on higher transactions

Stocks today witnessed flat with falling trend of most of the major price indices at Dhaka and Chattogram Stock Exchanges despite higher transactions.

Precarious predicament of vaccine procurement

Precarious predicament of vaccine procurement

Vaccines are basically the government’s responsibility. Once the vaccines are procured and distributed, then the people can be told to get vaccinated, to be registered. But how to get the vaccine?

Serum Institute is manufacturing the Oxford-AstraZeneca vaccine in India

Serum vaccine: Contract has non-liability clause

The three parties to the contract are Bangladesh government, Beximco Pharma and India's Serum Institute

Beximco makes 77 taka profit on each dose of Covid vaccine

Beximco makes 77 taka profit on each dose of Covid vaccine

Beximco Pharmaceuticals' profits have gone up by almost 62.5 per cent compared to the corresponding period of the previous year

A small vial labeled with a "Vaccine" sticker

Covid-19: Why the crisis in vaccines?

Vaccine supply has emerged globally as an extremely sensitive political issue. The disparity between nations is the main cause of this predicament.

Health minister Zahid Maleque talks to media during a press briefing on the premises of Bangladesh College of Physicians and Surgeons, Dhaka on 27 April 2021

No crisis of oxygen in Bangladesh: Health minister

Health minister Zahid Maleque has said the uncertainty over receiving coronavirus vaccine jabs from the Serum Institute of India is likely to be over soon

Vaccine diplomacy, India’s ban, lessons learned

Covid-19 Vaccine diplomacy, India’s ban, lessons learned

Bangladesh has seen a significant increase in the number of deaths during the second wave of coronavirus. Next door in India the virus is spreading like wildfire. This is a grave warning to us

Editorial

Uncertainty of vaccine availability must be cleared immediately

As the second wave of coronavirus hits the country, Bangladesh is uncertain over supply of the required vaccine. The matter requires an immediate solution to avert a crisis

No vaccine export for the time being, says India

No vaccine export for the time being, says India

Bangladesh remains uncertain about when it will receive the next consignment of Covid vaccines from India as per agreement. This has pitched the country's vaccination drive into uncertainty as the ...

Nazmul Hassan alias Papon

Serum has no right to halt vaccine supply as payment made in advance: Papon

The Serum Institute of India has no right to halt the supply of vaccines of novel coronavirus (Covid-19) as Bangladesh has paid in advance for the vaccines, said Beximco Pharmaceuticals managing ...

Load More